期刊
ONCOIMMUNOLOGY
卷 3, 期 6, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.29288
关键词
breast cancer; PD-L1; immunotherapy; tumor infiltrating lymphocytes
Upon analysis of 636 primary breast carcinoma patient samples, we have found that programmed cell death ligand 1 (PD-L1) mRNA expression is associated with tumor-infiltrating lymphocytes (TILs). Furthermore, PD-L1 expression and elevated TILs were associated with longer recurrence-free survival. Thus, our findings indicate that PD-L1 is prognostic in breast cancer and suggests a functional link between TILs and tumor PD-L1 upregulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据